BVAC-C vaccine (Cellid)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameBVAC-C vaccine (Cellid)
Drug Alias NameBVAC C
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionHelper-inducer T-lymphocytes stimulantsNatural killer cells stimulantsCytotoxic T lymphocytes stimulants +[5] 
TargetsT-cell receptor
Therapy Area/IndicationsUterine Cervical Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCellid Company
China Registration ClassN/A

Develop Information

Active CompaniesCellid Co Ltd
Inactive CompaniesN/A
Active IndicationsUterine Cervical Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A